Metastases in Prostate Cancer.

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Cold Spring Harbor Perspectives in Medicine

• Publication date

  2019-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/cshperspect.a033688PMID 29661810PMCID PMC6396340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating and disseminated tumor cells: harbingers or initiators of metastasis?

  2017cited by this paper
• Bisphosphonates for advanced prostate cancer.

  2017cited by this paper
• "The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894" (1894), by William Stewart Halsted

  2017cited by this paper
• The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer

  2016cited by this paper
• The biology of circulating tumor cells

  2016cited by this paper
• Mouse models for studying prostate cancer bone metastasis.

  2016cited by this paper
• Biology of Bone Metastases in Prostate Cancer.

  2016cited by this paper
• Divergent clonal evolution of castration resistant neuroendocrine prostate cancer

  2016cited by this paper
• Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone

  2016cited by this paper
• EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer

  2015cited by this paper
• The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone.

  2015cited by this paper
• Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.

  2015cited by this paper
• Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical Prostatectomy.

  2015influential reference
• Metastasis prevention by targeting the dormant niche

  2015influential reference
• The hematopoietic stem cell niche in homeostasis and disease.

  2015cited by this paper
• Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).

  2015cited by this paper
• Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer.

  2015cited by this paper
• Lymph Node Staging in Prostate Cancer

  2015cited by this paper
• Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone.

  2014cited by this paper
• Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways

  2014cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis

  2014cited by this paper
• The Molecular Signature of the Stroma Response in Prostate Cancer-Induced Osteoblastic Bone Metastasis Highlights Expansion of Hematopoietic and Prostate Epithelial Stem Cell Niches

  2014cited by this paper
• Mouse models of prostate cancer: picking the best model for the question

  2014cited by this paper
• Growth of LAPC4 prostate cancer xenograft tumor is insensitive to 5α-reductase inhibitor dutasteride.

  2014cited by this paper
• Distribution of metastatic sites in patients with prostate cancer: A population‐based analysis

  2014cited by this paper
• Insidious Changes in Stromal Matrix Fuel Cancer Progression

  2014cited by this paper
• Hematopoietic stem cell niche maintenance during homeostasis and regeneration

  2014cited by this paper
• The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials.

  2014influential reference
• Survival with newly diagnosed metastatic prostate cancer in the “docetaxel era”: Data from >600 patients in the control arm of the STAMPEDE trial (NCT00268476).

  2013cited by this paper
• The perivascular niche regulates breast tumor dormancy

  2013cited by this paper
• Perivascular Hair Follicle Stem Cells Associate with a Venule Annulus

  2013cited by this paper
• Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progression

  2013cited by this paper
• Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis.

  2013influential reference
• Tracking the clonal origin of lethal prostate cancer.

  2013cited by this paper
• Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment

  2013cited by this paper
• Rhythmic modulation of the hematopoietic niche through neutrophil clearance.

  2013cited by this paper
• Pattern and distribution of bone metastases in common malignant tumors.

  2013cited by this paper
• Targeting Constitutively Activated β1 Integrins Inhibits Prostate Cancer Metastasis

  2013cited by this paper
• Recruitment of Mesenchymal Stem Cells Into Prostate Tumors Promotes Metastasis

  2013cited by this paper
• Origins of metastatic traits.

  2013cited by this paper
• A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008

  2012cited by this paper
• Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases

  2012cited by this paper
• Biology of bone metastases.

  2012cited by this paper
• Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases.

  2012cited by this paper
• Stem‐Like Cells with Luminal Progenitor Phenotype Survive Castration in Human Prostate Cancer

  2012cited by this paper
• Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

  2012cited by this paper
• Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

  2012cited by this paper
• Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases.

  2012cited by this paper
• Monocytes-macrophages that express α-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow

  2012cited by this paper
• Interferon‐β‐induced miR‐155 inhibits osteoclast differentiation by targeting SOCS1 and MITF

  2012cited by this paper
• Advancing a clinically relevant perspective of the clonal nature of cancer

  2011cited by this paper
• Tumor metastasis: molecular insights and evolving paradigms.

  2011cited by this paper
• Cancer to bone: a fatal attraction

  2011influential reference
• A microRNA expression signature of osteoclastogenesis.

  2011cited by this paper
• Hematopoietic stem and progenitor cell trafficking.

  2011cited by this paper
• Epithelial plasticity, cancer stem cells and bone metastasis formation.

  2011cited by this paper
• Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

  2011cited by this paper
• Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone

  2011cited by this paper
• VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.

  2011cited by this paper
• Hematopoietic Stem Cell Niche Is a Potential Therapeutic Target for Bone Metastatic Tumors

  2011cited by this paper
• Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.

  2011cited by this paper
• Integrins and bone metastasis: integrating tumor cell and stromal cell interactions.

  2011cited by this paper
• Perivascular instruction of cell genesis and fate in the adult brain

  2011cited by this paper
• The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis

  2011cited by this paper
• Malignant cells facilitate lung metastasis by bringing their own soil

  2010cited by this paper
• Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors

  2010cited by this paper
• miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate

  2010cited by this paper
• Real-time imaging reveals the single steps of brain metastasis formation

  2010cited by this paper
• High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer.

  2010cited by this paper
• Cancer metastasis as a therapeutic target.

  2010cited by this paper
• CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.

  2010cited by this paper
• Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer

  2010cited by this paper
• Additional therapy for high-risk prostate cancer treated with surgery: what is the evidence?

  2009influential reference
• Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence

  2009cited by this paper
• Denosumab in men receiving androgen-deprivation therapy for prostate cancer.

  2009cited by this paper
• A luminal epithelial stem cell that is a cell of origin for prostate cancer

  2009cited by this paper
• Osteoclast‐specific Dicer gene deficiency suppresses osteoclastic bone resorption

  2009cited by this paper
• Impaired Micro-RNA Pathways Diminish Osteoclast Differentiation and Function*

  2009cited by this paper
• Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancer.

  2009cited by this paper
• Mechanically Activated Integrin Switch Controls α5β1 Function

  2009cited by this paper
• Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer.

  2008cited by this paper
• Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

  2008cited by this paper
• Haematopoietic stem cell release is regulated by circadian oscillations

  2008cited by this paper
• Prostate cancer stem cells: a new target for therapy.

  2008cited by this paper
• Muscle satellite cells and endothelial cells: close neighbors and privileged partners.

  2007cited by this paper
• Unusual and underappreciated: small cell carcinoma of the prostate.

  2007cited by this paper
• Models, mechanisms and clinical evidence for cancer dormancy

  2007cited by this paper
• BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.

  2007cited by this paper
• Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases

  2007cited by this paper
• Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases

  2007cited by this paper
• Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.

  2007cited by this paper
• Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.

  2007cited by this paper
• Bisphosphonates for advanced prostate cancer.

  2006cited by this paper
• Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo.

  2005cited by this paper
• Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer.

  2005cited by this paper
• SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor*

  2005cited by this paper
• Prospective identification of tumorigenic prostate cancer stem cells.

  2005cited by this paper
• A pooled analysis of bone marrow micrometastasis in breast cancer.

  2005cited by this paper
• Bone turnover mediates preferential localization of prostate cancer in the skeleton.

  2005influential reference

• SOX2 expression in the primary tumor of castration-naive metastatic prostate adenocarcinoma in association with metastasis extent

  2026cites this paper
• Analyzing foundation models for segmentation of osseous metastatic lesions in prostate cancer on CT scans

  2026cites this paper
• Characterising the effect of circulating sphingolipids on metastatic prostate cancer cells

  2025cites this paper
• Nanoparticle-based drug delivery systems in urologic oncology: From targeted therapy to precision theranostics

  2025cites this paper
• Advancing 3D scaffold models for metastatic prostate cancer in bone: Materials, manufacture, and future perspectives

  2025cites this paper
• A Feasibility Study of Co-Established Patient-Derived Subcutaneous Xenograft and Organotypic Slice Cultures in Hormone-Naive Primary Prostate Cancer Preclinical Modeling: A Single-Institution Experience

  2025cites this paper
• MicroRNAs in bone metastases: mechanisms and research progression

  2025cites this paper
• Targeting Urokinase-type plasminogen activator receptor (uPAR) in cancer therapy: Insights from the development of small-molecule inhibitors.

  2025cites this paper
• Osteosclerotic changes on computed tomography predict disease progression and poor survival in prostate cancer with osteoblastic metastases

  2025cites this paper
• Homotypic biomimetic nanotheranostics enhance locoregional Cherenkov radiation-induced photodynamic therapy and ferroptosis in early bone metastases.

  2025cites this paper
• The role and mechanisms of exosome microRNA in regulating metastasis within the tumor microenvironment of prostate cancer

  2025cites this paper
• PTEN Mutations Associated with Increased Recurrence and Decreased Survival in Patients with Prostate Cancer Spinal Metastasis

  2025cites this paper
• Comparing prostatype P-score and traditional risk models for predicting prostate cancer outcomes in Spain.

  2025cites this paper
• CEG-0598, a novel dual inhibitor of EGFR and C5aR demonstrates in vitro anticancer and antimetastatic activity in prostate cancer cells

  2025cites this paper
• A Subepithelial Lesion in the Colon Masquerading as Metastatic Prostate Cancer

  2025cites this paper
• Bromodomain and Extra-Terminal Family Proteins BRD2, BRD3, and BRD4 Contribute to H19-Dependent Transcriptional Regulation of Cell Adhesion Molecules, Modulating Metastatic Dissemination Program in Prostate Cancer

  2025cites this paper
• Bone marrow adipocytes in cancer: Mechanisms, models, and therapeutic implications.

  2025cites this paper
• Prostate Cancer With Orbital Metastasis

  2025cites this paper
• Docetaxel‐Loaded, Dipeptide‐Functionalized γ‐Fe2O3 Magnetic Nanoparticles: Synthesis, Characterization, and Targeting to Prostate Cancer

  2025cites this paper
• Bone metastases of prostate cancer: Molecular mechanisms, targeted diagnosis and targeted therapy (Review)

  2025cites this paper
• Mechanical Loading of Osteocytes via Oscillatory Fluid Flow Regulates Early‐Stage PC‐3 Prostate Cancer Metastasis to Bone

  2025cites this paper
• Factors Associated with Potentially Inappropriate Prescribing in Patients with Prostate Cancer

  2025cites this paper
• Enhancing in Vitro Anti-metastatic Efficacy and Deep Penetration into Tumor Spheroid of Docetaxel-Loaded Liposomes via Size Optimization for Prostate Cancer Treatment

  2025cites this paper
• Baseline Imaging Derived Factors of Response Following [225Ac]Ac‐J591 Therapy in Metastatic Castration‐Resistant Prostate Cancer: A Lesion Level Analysis

  2025cites this paper
• Tantangan Implementasi Imunoterapi Chimeric Antigen Receptor T-Cell (CAR-T) pada Lingkungan-Mikro Kanker Prostat

  2025cites this paper
• Lymphangitic Carcinomatosis Presenting as Cough: A Case of Occult Metastatic Prostate Adenocarcinoma

  2024cites this paper
• Gαi2 Protein Inhibition Blocks Chemotherapy- and Anti-Androgen-Induced Prostate Cancer Cell Migration

  2024cites this paper
• A trinuclear Zn (II) schiff base dicyanamide complex attenuates bacterial biofilm formation by ROS generation and membrane damage and exhibits anticancer activity.

  2024cites this paper
• Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer

  2024cites this paper
• Recent Trends in Nanocarrier-Based Drug Delivery System for Prostate Cancer

  2024cites this paper
• The role of diffusion-weighted MRI in the evaluation of imaging for prostate carcinoma: A systematic review

  2024cites this paper
• Incidence of exclusive extrapelvic skeletal metastasis in prostate carcinoma on bone scintigraphy

  2024cites this paper
• The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells

  2024cites this paper
• Role of osteoclast inhibitors in prostate cancer bone metastasis; a narrative review

  2024cites this paper
• Traditional Prostate Cancer Risk Assessment Scales Do Not Predict Outcomes from Brain Metastases: A Population-Based Predictive Nomogram

  2024cites this paper
• Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editing

  2024cites this paper
• Evaluation of the Prognostic Role of TP53 Gene Mutations in Prostate Cancer Outcome: A Systematic Review and Meta-Analysis.

  2024cites this paper
• Novel systems biology experimental pipeline reveals matairesinol’s antimetastatic potential in prostate cancer: an integrated approach of network pharmacology, bioinformatics, and experimental validation

  2024cites this paper
• Skeletal Metastasis of Prostate Cancer Is Augmented by Activation of EphA2 Noncanonical Signaling and Ligand-Deficient Bone Microenvironment

  2024cites this paper
• Prognostic Impact of H19/Cell Adhesion Molecules Circuitry on Prostate Cancer Biopsy

  2024cites this paper
• Synthesis, molecular docking, ADMET profiling, and anti-PC3 activity of new Schiff base derivatives

  2024cites this paper
• CRISPR/Cas9 Technology Providing the Therapeutic Landscape of Metastatic Prostate Cancer

  2024cites this paper
• Components of the Endosome-Lysosome Vesicular Machinery as Drivers of the Metastatic Cascade in Prostate Cancer

  2024cites this paper
• Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer.

  2023cites this paper
• Prostate cancer metastasis and health disparities: a systematic review

  2023cites this paper
• Skull metastasis is a poor prognostic factor for prostate cancer patients with bone metastasis: a retrospective study based on a Chinese population

  2023cites this paper
• GelMA and Biomimetic Culture Allow the Engineering of Mineralized, Adipose, and Tumor Tissue Human Microenvironments for the Study of Advanced Prostate Cancer In Vitro and In Vivo

  2023cites this paper
• Analysis of Clinical Trials and Review of Recent Advances in Therapy Decisions for Locally Advanced Prostate Cancer

  2023cites this paper
• A mononuclear N,N,N,O donor schiff base Cu(II) complex inhibits bacterial biofilm formation and promotes apoptosis and cell cycle arrest in prostate cancer cells.

  2023cites this paper
• scTIGER: A Deep-Learning Method for Inferring Gene Regulatory Networks from Case versus Control scRNA-seq Datasets

  2023cites this paper
• Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase

  2023cites this paper
• Prediction of Metastatic Site Based On Somatic Gene Mutations in Primary Tumors in Prostate Cancer

  2023cites this paper
• Obesity and prostate cancer — microenvironmental roles of adipose tissue

  2023cites this paper
• Prostate organoids: emerging experimental tools for translational research

  2023cites this paper
• Green Nanoformulations of Polyvinylpyrrolidone-Capped Metal Nanoparticles: A Study at the Hybrid Interface with Biomimetic Cell Membranes and In Vitro Cell Models

  2023cites this paper
• Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

  2022cites this paper
• Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies

  2022cites this paper
• The role of KiSS1 gene on the growth and migration of prostate cancer and the underlying molecular mechanisms.

  2022cites this paper
• Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine

  2022cites this paper
• Gender dimorphism in survival of patients with lymph node metastasis of bladder cancer

  2022cites this paper
• Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective

  2021cites this paper
• An Innovative Prostate Cancer Detection Method via Model Checking

  2021cites this paper
• Formal Methods for Prostate Cancer Gleason Score and Treatment Prediction using Radiomic Biomarkers.

  2020cites this paper
• Implication of Prophetic Variables and Their Impulsive Interplay in CA Prostate Patients Experiencing Osteo-Metastasis.

  2020cites this paper
• The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis

  2020cites this paper
• Effects of the Bone/Bone Marrow Microenvironments on Prostate Cancer Cells and CD59 Expression

  2020cites this paper
• A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges

  2019cites this paper
• Three-Dimensional-Printed Bioceramic Scaffolds with Osteogenic Activity for Simultaneous Photo/Magnetothermal Therapy of Bone Tumors.

  2019cites this paper
• Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients

  2019cites this paper
• Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer

  2019cites this paper
• COMMD3:BMI1 Fusion and COMMD3 Protein Regulate C-MYC Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer

  2019cites this paper
• Prostate Gleason Score Detection and Cancer Treatment Through Real-Time Formal Verification

  2019cites this paper
• Hormonally induced defects of DNA damage repair genes: an oncogenic driver of prostate cancer

  2018cites this paper
• Based Approaches to Cancer Diagonsis and Therapy

  2018cites this paper
• Radiochemical studies, pre-clinical investigation and preliminary clinical evaluation of 170Tm-EDTMP prepared using in-house freeze-dried EDTMP kit.

  2017cites this paper